WEDNESDAY, Oct. 22, 2025 (HealthDay News) — For the estimated one-third of people with focal epilepsy who don’t respond well to initial medications, new research offers significant reason for optimism.  A study suggests that even those considered “treatment-resistant” may eventually see a substantial reduction in their seizures over time. FocalContinue Reading

SUNDAY, Oct. 12, 2025 (HealthDay News) — A new study from Case Western Reserve University suggests a major shift in schizophrenia treatment: One that focuses on helping patients better interpret social cues. “We’ve been treating schizophrenia with a one-size-fits-all approach for decades,” Jessica Wojtalik, an assistant professor at the ClevelandContinue Reading

FRIDAY, Sept. 26, 2025 (HealthDay News) — A new gene therapy has shown promise in slowing the progression of Huntington’s disease, according to early trial results released Wednesday. In a Phase 1/2 study, patients given a high dose of UniQure’s experimental therapy AMT-130 experienced a 75% slowing of disease progressionContinue Reading

THURSDAY, Sept. 25, 2025 (HealthDay News) — People with spinal cord injuries sometimes suffer from blood pressure problems, as their brain loses the ability to manage the body’s blood pressure. This leaves them vulnerable to blood pressure drops that cause fainting or spikes that put them at risk of aContinue Reading

THURSDAY, Sept. 25, 2025 (HealthDay News) — Skin-to-skin contact might help kick-start brain development in preterm babies, a new study says. Preemies born before 32 weeks showed stronger development in brain regions tied to emotion and stress regulation if they received more skin-to-skin contact, researchers reported Sept. 24 in theContinue Reading